Evidence map›Paper›PMID 23195629›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2013

Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-A.

James R Klinger, Shu-Whei Tsai, Sabrina Green, Katie L Grinnell, Jason T Machan, Elizabeth O Harrington

Abstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Deletion of thePulmonary circulation · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

James R KlingerVascular Research Laboratory, Veterans Affairs Medical Center, Providence, RI, USA. James_Klinger@brown.edu
Shu-Whei Tsai
Sabrina Green
Katie L Grinnell
Jason T Machan
Elizabeth O Harrington
Veterans Health Administration · USBrown University · USProvidence College · US

Funding

Endothelial Barrier Function Modulation by PKCDeltaR01HL067795 · NHLBI · BROWN UNIVERSITY · PI HARRINGTON, ELIZABETH O · 2001 to 2011
$3.0M
Brown CardioPulmonary Research Training ProgramT32HL094300 · NHLBI · RHODE ISLAND HOSPITAL · PI KOREN, GIDEON · 2008 to 2012
$2.2M
Natriuretic Peptides in Pulmonary Endothelial Cell Barrier FunctionR01HL088328 · NHLBI · RHODE ISLAND HOSPITAL · PI KLINGER, JAMES RAYMOND · 2007 to 2011
$1.6M
NHLBI NIH HHS HL-088328NHLBI NIH HHS HL-088328-03S1NHLBI NIH HHS HL67795NHLBI NIH HHS R01 HL067795NHLBI NIH HHS T32 HL094300
6 · The paper itself

Abstract

Atrial natriuretic peptide (ANP) inhibits agonist-induced pulmonary edema formation, but the signaling pathway responsible is not well defined. To investigate the role of the particulate guanylate cyclase-linked receptor, natriuretic peptide receptor-A (NPR-A), we measured acute lung injury responses in intact mice and pulmonary microvascular endothelial cells (PMVEC) with normal and disrupted expression of NPR-A. NPR-A wild-type (NPR-A+/+), heterozygous (NPR-A+/-), and knockout (NPR-A-/-) mice were anesthetized and treated with thrombin receptor agonist peptide (TRAP) or lipopolysaccharide (LPS). Lung injury was assessed by lung wet-to-dry (W/D) weight and by protein and cell concentration of bronchoalveolar lavage (BAL) fluid. No difference in pulmonary edema formation was seen between NPR-A genotypes under baseline conditions. TRAP and LPS increased lung W/D weight and BAL fluid cell counts more in NPR-A-/- mice than in NPR-A+/- or NPR-A+/+ mice, but no genotype-related differences were seen in TRAP-induced increases in bloodless lung W/D weight or LPS-induced increases in BAL protein concentration. Pretreatment with ANP infusion completely blocked TRAP-induced increases in lung W/D weight and blunted LPS-induced increases in BAL cell counts and protein concentration in both NPR-A-/- and NPR-A+/+ mice. Thrombin decreased transmembrane electrical resistance in monolayers of PMVECs in vitro, and this effect was attenuated by ANP in PMVECs isolated from both genotypes. Administration of the NPR-C-specific ligand, cANF, also blocked TRAP-induced increases in lung W/D weight and LPS-induced increases in BAL cell count and protein concentration in NPR-A+/+ and NPR-A-/- mice. We conclude that ANP is capable of attenuating agonist-induced lung edema in the absence of NPR-A. The protective effect of ANP on agonist-induced lung injury and pulmonary barrier function may be mediated by NPR-C.

Indexed as

AnimalsAtrial Natriuretic FactorBronchoalveolar Lavage FluidCapillary PermeabilityCells, CulturedEndothelial CellsEndothelium, VascularLipopolysaccharidesLung InjuryMiceNatriuretic Peptide, C-TypePulmonary EdemaReceptors, Atrial Natriuretic FactorReceptors, Guanylate Cyclase-CoupledReceptors, PeptideReceptors, ThrombinAtrial Natriuretic Factoratrial natriuretic factor receptor ALipopolysaccharidesNatriuretic Peptide, C-TypeReceptors, Atrial Natriuretic FactorReceptors, Guanylate Cyclase-CoupledReceptors, PeptideReceptors, ThrombinThrombin

Identifiers

PMID23195629
PMCPMC3568874
OpenAlexW2139411454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.